Vaccination is cardinal in restraining the pandemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The increased risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) makes vaccination particularly relevant in this population (1).
Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study